ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.610
+0.190 (13.38%)
At close: Aug 21, 2026, 4:00 PM EDT
1.590
-0.020 (-1.24%)
After-hours: Aug 21, 2026, 7:41 PM EDT
ProKidney Revenue
ProKidney had revenue of $150.00K in the quarter ending June 30, 2026, a decrease of -32.13%. This brings the company's revenue in the last twelve months to $818.00K, up 55.22% year-over-year. In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth.
Revenue (ttm)
$818.00K
Revenue Growth
+55.22%
P/S Ratio
595.04
Revenue / Employee
$3,541
Employees
231
Market Cap
486.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Editas Medicine | 47.01M |
| vTv Therapeutics | 36.84M |
| Foghorn Therapeutics | 36.74M |
| X4 Pharmaceuticals | 15.85M |
| Compass Therapeutics | 850.00K |
| Inhibikase Therapeutics | 1.00 |
PROK News
- 11 days ago - ProKidney reports Q2 EPS (15c), consensus (14c) - TheFly
- 12 days ago - ProKidney Quarterly report: Q2 2026 - Filings
- 12 days ago - ProKidney Earnings release: Q2 2026 - Filings
- 2 months ago - ProKidney Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - ProKidney appoints Kenneth Locke as chief technical officer - TheFly
- 2 months ago - ProKidney Appoints Kenneth Locke as Chief Technical Officer - GlobeNewsWire
- 3 months ago - ProKidney Transcript: AGM 2026 - Transcripts
- 3 months ago - ProKidney reports Q1 EPS (14c), consensus (14c) - TheFly